A ABCELLERA BIOLOGICS INC
| Market Cap | $1.07B |
| P/E Ratio | — |
| Forward P/E | -4.57 |
| Dividend Yield | — |
| Beta | 0.85 |
| 52W Range | $1.93 - $6.17 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Polen Capital Management Polen Capital Management | 0.00% | $350.00K | 102,508 | Reduce 61.93% |
Insider Trading
| Insider Name of the company insider who made the trade 5 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Booth AndrewChief Financial Officer | Buy | 42,600 | $3.42 | $145.69K | 27 Feb 2026 | 27 Feb 2026 |
| Thermopylae Holdings Ltd. | Buy | 38,000 | $3.44 | $130.72K | 27 Feb 2026 | 02 Mar 2026 |
| Thermopylae Holdings Ltd. | Buy | 177,457 | $3.27 | $580.28K | 26 Feb 2026 | 27 Feb 2026 |
| Montalbano John S. | Buy | 50,000 | $3.57 | $178.46K | 26 Nov 2025 | 26 Nov 2025 |
| John S. MontalbanoDirector | Buy | 50,000 | $3.57 | $178.46K | 26 Nov 2025 | 26 Nov 2025 |
Frequently Asked Questions
What is ABCL stock price today?
ABCELLERA BIOLOGICS INC (ABCL) is currently trading at $3.52. The stock has a 52-week range of $1.93 to $6.17 and a market capitalization of $1.07B.
Is ABCL a good stock to buy in 2026?
ABCELLERA BIOLOGICS INC has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of +68.4%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling ABCL stock?
There have been 5 insider transactions for ABCL in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has ABCL stock performed over the past year?
ABCELLERA BIOLOGICS INC (ABCL) has returned +68.4% over the past 12 months. The stock traded between $1.93 and $6.17 during this period, and is currently at $3.52.
Which hedge funds own ABCL (ABCELLERA BIOLOGICS INC)?
1 tracked hedge funds currently hold ABCL in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is ABCL's market cap and valuation?
ABCELLERA BIOLOGICS INC (ABCL) has a market capitalization of $1.07B. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is ABCL's revenue and profitability?
ABCELLERA BIOLOGICS INC reported revenue of $75.13M with net income of N/A and a profit margin of N/A. The stock has a beta of 0.85.
What sector is ABCL in and who are its biggest institutional holders?
ABCELLERA BIOLOGICS INC (ABCL) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.